Key result
Inhibition of the renin-angiotensin system (RAS) is highlighted as the most effective intervention to prevent or slow the progression of chronic kidney disease.
Why the study?
The incidence and prevalence of chronic kidney disease are increasing worldwide, necessitating effective interventions to prevent or slow its progression.
Does inhibition of the renin-angiotensin system prevent or slow the progression of chronic kidney disease?
Does inhibition of the renin-angiotensin system prevent or slow the progression of chronic kidney disease?
Inhibition of the renin-angiotensin system is highlighted as the most effective intervention for the primary and secondary prevention of chronic kidney disease.
The incidence and prevalence of chronic kidney disease (CKD) is on the rise worldwide. End-stage renal disease (ESRD) is the most advanced form of CKD, requiring some form of renal replacement therapy to ensure survival. Interventions to prevent or slow the progression of CKD, irrespective of the original cause, are thus of significant importance. The most effective of these interventions is based on the inhibition of the renin-angiotensin system (RAS) and is the main focus of this review.
No takes yet. Share an insight, caveat, or question.
Zandi‐Nejad et al. (2005) conducted a review in Chronic kidney disease (CKD). Inhibition of the renin-angiotensin system (RAS) was evaluated on Prevention or slowing of CKD progression. Inhibition of the renin-angiotensin system (RAS) is highlighted as the most effective intervention to prevent or slow the progression of chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: